Logo

Liver Metastases of Pancreatic Cancer: Role of Repetitive Transarterial Chemoembolization (TACE) on Tumor Response and Survival

Author(s):
Alireza AziziAlireza Azizi1,*, Nagy NaghybNagy Naghyb1, Parviz FarshidParviz Farshid1, Emanuel M.BalisikeEmanuel M.Balisike1, Thomas J.VoglThomas J.Vogl1
1Johann Wolfgang Goethe University Hospital, Frankfurt, Germany


Published online:Feb 28, 2014
Article type:Research Article
How to Cite:Alireza AziziNagy NaghybParviz FarshidEmanuel M.BalisikeThomas J.VoglLiver Metastases of Pancreatic Cancer: Role of Repetitive Transarterial Chemoembolization (TACE) on Tumor Response and Survival.I J Radiol.11(30th Iranian Congress of Radiology):e21438.https://doi.org/10.5812/iranjradiol.21438.

Abstract

Background:

The study was conducted to evaluate the effect of chemoembolization on pancreatic cancer liver metastases.

Patients and Methods:

Thirty-two patients with pancreatic cancer liver metastases who had underwent chemoembolization (48 weeks intervals) were retrospectively enrolled into this study. Size based evaluation (RECIST) and survival indexes were assessed in general and for gender and number of lesions.

Results:

71.87% of patients showed stable disease (SD), 9.37% partial response (PR) and 18.75% progressive disease (PD). Survival rate for 1-, 3-, and 5-years from first TACE was 60%, 25%, and 11% respectively. Median survival time was 16 months and for SD group was 20 months. Progression-free survival for 6 month, 1-, 3- and 5-years was 84%, 57.3%, 20%, and 10%, respectively. There was statistically significant difference between male and female patients in their response. Survival rate for 1- and 5-years for males was 80% and 14% and for females was 47% and 0%. There was no significant difference between oligonodular liver lesion (less than 5) and multinodular (more than 5) groups. Survival rate for 1-and 5-years for oligonodular was 84% and 14% and for multinodular was 50% and 0% respectively.

Conclusions:

Repetitive TACE resulted in a relevant response for the control of liver metastases of pancreatic cancer with considerable median survival time. Interestingly, this study was limited by the low number of subjects to produce significant results.

Full Text

Full text is available in PDF

comments

Leave a comment here


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles